0000899866-17-000008.txt : 20170109
0000899866-17-000008.hdr.sgml : 20170109
20170109172140
ACCESSION NUMBER: 0000899866-17-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170105
FILED AS OF DATE: 20170109
DATE AS OF CHANGE: 20170109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 2032722596
MAIL ADDRESS:
STREET 1: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PARVEN ALVIN S
CENTRAL INDEX KEY: 0001231950
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 17518626
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS INC
STREET 2: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06410
4
1
wf-form4_148400047056942.xml
FORM 4
X0306
4
2017-01-05
0
0000899866
ALEXION PHARMACEUTICALS INC
ALXN
0001231950
PARVEN ALVIN S
C/O ALEXION PHARMACEUTICALS, INC
100 COLLEGE STREET
NEW HAVEN
CT
06510
1
0
0
0
Common Stock, par value $.0001 per share
2017-01-05
4
M
0
7932
26.64
A
14305
D
Common Stock, par value $.0001 per share
2017-01-05
4
M
0
5572
49.43
A
19877
D
Common Stock, par value $.0001 per share
2017-01-05
4
M
0
3237
85.75
A
23114
D
Common Stock, par value $.0001 per share
2017-01-05
4
M
0
3425
96.35
A
26539
D
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
185
133.95
D
26354
D
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
369
135.70
D
25985
D
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
7375
137.56
D
18610
D
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
5176
138.60
D
13434
D
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
5350
139.49
D
8084
D
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
1433
140.59
D
6651
D
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
278
141.23
D
6373
D
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
853
133.65
D
5520
I
by spouse's trust
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
15
133.95
D
5505
I
by spouse
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
31
135.69
D
5474
I
by spouse
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
599
137.56
D
4875
I
by spouse
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
421
138.60
D
4454
I
by spouse
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
435
139.49
D
4019
I
by spouse
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
117
140.59
D
3902
I
by spouse
Common Stock, par value $.0001 per share
2017-01-05
4
S
0
22
141.22
D
3880
I
by spouse
Option to Purchase Common Stock
26.64
2017-01-05
4
M
0
7932
0
D
2010-08-12
2020-05-12
Common Stock, par value $.0001 per share
7932.0
0
D
Option to Purchase Common Stock
49.43
2017-01-05
4
M
0
5572
0
D
2011-08-11
2021-05-11
Common Stock, par value $.0001 per share
0.0
0
D
Option to Purchase Common Stock
85.75
2017-01-05
4
M
0
3237
0
D
2012-08-08
2022-05-08
Common Stock, par value $.0001 per share
3237.0
0
D
Option to Purchase Common Stock
96.35
2017-01-05
4
M
0
3425
0
D
2013-08-07
2023-05-07
Common Stock, par value $.0001 per share
3425.0
0
D
This transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $133.95 - $134.95. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $135.22 - $136.22. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $137.04 - $138.04. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $138.05 - $139.05. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $139.08 - $140.08. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $140.13 - $141.13. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $141.17 - $142.17. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $133.65 - $134.65. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
/s/ Michael Greco Attorney-in-Fact for Alvin Parven
2017-01-09